| |
| |
|
| Insider
Information: |
Do Hung |
| Relationship: |
Chief Science Officer |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
448,617 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,759,826 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
448,617 |
|
|
| Total
Value |
$4,759,826 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
Chief Science Officer |
2021-04-06 |
448,617 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President DiscoveryOff |
• – – |
2013-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,399,799 |
|
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-03-07 |
4 |
D |
$2.32 |
$158,730 |
D/D |
(68,418) |
1,331,361 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-03-10 |
4 |
D |
$2.28 |
$246,281 |
D/D |
(108,018) |
1,223,343 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-03-11 |
4 |
D |
$2.22 |
$270,045 |
D/D |
(121,642) |
1,101,701 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-03-12 |
4 |
D |
$2.21 |
$187,921 |
D/D |
(85,032) |
1,016,669 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-03-14 |
4 |
D |
$2.26 |
$49,867 |
D/D |
(22,065) |
994,604 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-12-19 |
4 |
D |
$7.88 |
$326,555 |
D/D |
(41,441) |
953,163 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2014-12-22 |
4 |
D |
$8.43 |
$349,348 |
D/D |
(41,441) |
911,722 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2015-01-23 |
4 |
D |
$8.10 |
$335,548 |
D/D |
(41,441) |
870,281 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2015-02-24 |
4 |
D |
$8.43 |
$349,493 |
D/D |
(41,441) |
828,840 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2015-03-25 |
4 |
D |
$10.84 |
$449,307 |
D/D |
(41,441) |
787,399 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Sr Vice President Discovery |
• – – |
2015-04-27 |
4 |
D |
$11.46 |
$474,930 |
D/D |
(41,441) |
745,958 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2015-05-27 |
4 |
D |
$11.77 |
$59 |
D/D |
(5) |
745,953 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2015-09-15 |
4 |
AS |
$17.75 |
$443,668 |
D/D |
(25,000) |
720,953 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
633,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-08-04 |
4 |
AS |
$7.00 |
$175,000 |
D/D |
(25,000) |
608,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-09-06 |
4 |
AS |
$7.00 |
$175,000 |
D/D |
(25,000) |
583,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-10-03 |
4 |
AS |
$7.25 |
$181,250 |
D/D |
(25,000) |
558,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2016-11-01 |
4 |
AS |
$7.00 |
$175,000 |
D/D |
(25,000) |
533,453 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,813 |
584,266 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-01-13 |
4 |
AS |
$6.00 |
$150,000 |
D/D |
(25,000) |
559,266 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-02-07 |
4 |
AS |
$6.00 |
$150,000 |
D/D |
(25,000) |
534,266 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-05-15 |
4 |
AS |
$8.00 |
$239,312 |
D/D |
(29,914) |
504,352 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-05-19 |
4 |
AS |
$8.00 |
$239,312 |
D/D |
(29,914) |
474,438 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chief Science Officer |
• – – |
2017-06-15 |
4 |
D |
$8.79 |
$10,820 |
D/D |
(1,231) |
473,207 |
0 |
- |
|
60 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
